As the number of COVID-19 cases continues to rise, oral treatment options for at-home use are in demand to provide early intervention and reduce the progression to severe disease, hospitalization, and death.
Kristin L. Feick, PHARMD, BCPS
Advertisement
Kristin Feick, PharmD, BCPS, is a PGY2 critical care pharmacy resident at Temple University School of Pharmacy in Philadelphia, Pennsylvania.
Articles by Kristin L. Feick, PHARMD, BCPS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
Moderna Discontinues Development of Vaccine for Congenital CMV After Not Meeting Primary Efficacy Endpoint
2
Meet SIDP’s President Elect: Lisa Dumkow, PharmD, FIDP, BCIDP
3
Dynavax Presents Data for Shingles Vaccine, Launches Head-to-Head Study Against Shingrix
4
Introducing Cefiderocol Earlier in Difficult-to-Treat-Infections
5
